Validation of a large volume-solid phase extraction methodology for biotoxicity assessment of pharmaceuticals in aquatic organisms

dc.contributor
Universitat Ramon Llull. IQS
dc.contributor.author
Moragrega-Knol, Emma
dc.contributor.author
Romero Alfano, Irene
dc.contributor.author
Barata, Carlos
dc.contributor.author
Gomez, Cristian
dc.date.accessioned
2025-10-11T11:01:21Z
dc.date.issued
2025-09-15
dc.identifier.issn
1873-6424
dc.identifier.uri
http://hdl.handle.net/20.500.14342/5589
dc.description.abstract
The growing scarcity of freshwater has intensified the need for alternative water sources, which often require advanced treatments to eliminate contaminants. Among emerging pollutants, pharmaceuticals have become a significant concern due to their persistence and potential impact, making their detection essential. However, analysing these contaminants is challenging due to the extremely low concentrations at which they are present. For chemical analysis, minimal or no sample enrichment is often necessary, while bioanalysis typically requires larger sample volumes and an enrichment factor to conduct comprehensive bioassays across various endpoints. Consequently, sample preconcentration techniques for large water volumes are necessary to improve the sensitivity of subsequent toxicological experiments. In this study, a novel large volume solid-phase extraction (LV-SPE) procedure was validated and evaluated for monitoring multiple pharmaceutical compounds in water samples, while maintaining the traditional solid-phase extraction (SPE) methodology using cartridges. This method proved effective extraction and preconcentration of significant amounts of water, with recoveries between 19 % and 109 % in spiked wastewaters (except for fluvoxamine, remdesivir, tamoxifen and tetracycline, with recoveries <10 %). Furthermore, the optimization of this approach covers an expansive chemical space, enabling the capture of a diverse range of pharmaceutical compounds and enhancing the validity of toxicological studies. Bioassays conducted with Daphnia magna juveniles and Danio rerio embryos validated the method's applicability regarding optimized exposure conditions, the absence of adverse effects from SPE blanks or solvent controls and sensitivity in detecting effects across field samples. Overall, the LV-SPE approach enhances sensitivity and reliability for evaluating pharmaceutical mixtures' risks under realistic conditions.
dc.format.extent
p.27
dc.language.iso
eng
dc.publisher
Elsevier
dc.relation.ispartof
Environmental Pollution 2025, 381
dc.rights
© L'autor/a
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject
Pharmaceutical residues
dc.subject
Water quality
dc.subject
Large volume-solid phase extraction
dc.subject
Toxicology tests
dc.subject
LC-MS/MS
dc.subject
Indústria farmacèutica--Residus
dc.subject
Aigua--Qualitat
dc.subject
Toxicologia
dc.title
Validation of a large volume-solid phase extraction methodology for biotoxicity assessment of pharmaceuticals in aquatic organisms
dc.type
info:eu-repo/semantics/article
dc.subject.udc
502
dc.subject.udc
615
dc.description.version
info:eu-repo/semantics/acceptedVersion
dc.embargo.terms
24 mesos
dc.relation.projectID
info:eu-repo/grantAgreement/AEI-MCIN/PN I+D/TED2021-130845B-C31
dc.relation.projectID
info:eu-repo/grantAgreement/AEI-MCIN/PN I+D/TED2021-130845A-C32
dc.relation.projectID
info:eu-repo/grantAgreement/MCIU/PN I+D/PID2023-148502OB-C21
dc.relation.projectID
info:eu-repo/grantAgreement/MCIU/PN I+D/PID2023–148502OB-C22
dc.identifier.doi
https://doi.org/10.1016/j.envpol.2025.126622
dc.date.embargoEnd
2027-09-15T02:00:00Z
dc.rights.accessLevel
info:eu-repo/semantics/embargoedAccess


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

IQS [794]